Rönneikkö, Jukka
Huhtala, Heini
Finne-Soveri, Harriet
Valvanne, Jaakko
Jämsen, Esa
Funding for this research was provided by:
Tampere University
Article History
Received: 12 December 2022
Accepted: 15 October 2023
First Online: 26 October 2023
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations. The use of the MDS database and hospital discharge data in this study was approved by the authorities of City of Tampere (decisions of Director of Hospital Services December 16, 2014, August 30, 2016, and June 16, 2017, and Director of Services for the Aged June 20, 2017), and Tampere University Hospital (R20613). Because of the retrospective, register-based nature of this study, ethics board approval was not required and the authorities responsible for the data can grant access to the records retrospectively for certain purposes, including medical research without the participants’ informed consent, based on current national legislation (Act on the publicity of official documents 21.5.1999/6211999; Data protection act 5.12.2018/10502018) and European Union General Data Protection Regulation (General data protection regulation (GDPR), recital 157 2018). MDS-HC data has been collected to a national register since 2000, held by the National Institute for Health and Welfare, right under Ministry of Social Affairs and Health. At the time of founding the register, an ethical approval to collect these data twice every year until 2023, was obtained from the Ministry of social Affairs and Health.
: Not applicable.
: E.Jämsen: Payment for lectures (unrelated to the present study) by Orion Corporation (Espoo, Finland), Novartis Finland (Espoo, Finland) and Nutricia (Turku, Finland). Member of Finnish medical professionals’ associations.H.Finne-Soveri: Executive Vice President of interRAI Board.J.Rönneikkö, H.Huhtala, J.Valvanne: No competing financial or non-financial interests.